Cargando…
Polymer–lipid hybrid nanoparticles as potential lipophilic anticancer drug carriers
Nanocarrier systems are widely used for drug delivery applications, but limitations such as the use of synthetic surfactants, leakage of toxic drugs, and a poor encapsulation capacity remain as challenges. We present a new hybrid nanocarrier system that utilizes natural materials to overcome these l...
Autores principales: | Salel, Sedef, Iyisan, Banu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504175/ https://www.ncbi.nlm.nih.gov/pubmed/37713009 http://dx.doi.org/10.1186/s11671-023-03897-3 |
Ejemplares similares
-
Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy
por: Tahir, Nayab, et al.
Publicado: (2019) -
Edible solid lipid nanoparticles (SLN) as carrier system for antioxidants of different lipophilicity
por: Oehlke, Kathleen, et al.
Publicado: (2017) -
Enhancement of anticancer efficacy using modified lipophilic nanoparticle drug encapsulation
por: Lee, Puiyan, et al.
Publicado: (2012) -
Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]
Publicado: (2020) -
Nanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugs
por: Khan, Saba, et al.
Publicado: (2015)